SalioGen’s CEO on the company’s ‘Gene Coding’ approach to genetic medicine and an oral presentation today at #ASGCT2024 for its Stargardt disease program

Ochre Bio CEO Jack O'Meara discusses his company's focus on liver diseases and its recent Boehringer Ingelheim partnership

A pioneer in fragment based drug discovery, Harren Jhoti describes how Astex Pharma has contributed to three now approved medicines since its founding in Cambridge in 1999

The CEO of Bicycle Therapeutics illustrates the form and function of bicycles and highlights the company's programs

Scancell's CEO discusses her company's cancer immunotherapy programs

Exscientia's CEO shares a pipeline overview and learnings from being one of the first AI companies out front and to go public